Cupat, Erlinda G.
HRN: 21-28-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2022
CEFTRIAXONE 1G (VIAL)
04/27/2022
05/04/2022
IVT
2g
Q24
CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes